Even if the Orphan Drug Act were working properly, its enormous costs might outweigh its exiguous benefits. But it’s not working properly. Drug manufacturers are gaming the Act in at least three important ways. They’re the topic of this week’s Healthcare Triage.
Tag Archives: Extended Monopoly on Orphan Drugs
Healthcare Triage: Orphan Drugs: An Introduction
We at Healthcare Triage couldn’t be more excited about this month. We’re doing a whole month on orphan drugs, with the help of Nick Bagley. He wrote a lot about them, and we begged him to let us adapt his work into a series. This is the Introduction. Over the next few weeks, there will be three more. Enjoy!
HENRY KOTULA 